| Application no. and date | 17753704.0 (espacenet) (Federated) (European Patent Register), 20170214 | | Patent/reg. no. and date | DK/EP 3417294, 20211201 | | Publication date | 20181226 | | Priority no. and date | US 201662295421 P, 20160215 | | EP pub. no. and date |
EP 3417294 20181226 | | Effective date | | | Applicant/owner | Astrazeneca AB, 151 85 Södertälje, SE,
The United States of America, as Represented
By the Secretery, Department of Health and
Human Services, Office of Technology Transfer
6701 Rockledge Drive
Suite 700, MSC 7788
Bethesda, MD 20892 / US, US | | Applicant ref. no. | 1625291 | | Inventor | BARRY, Simon, AstraZeneca
Darwin Building
Cambrige Science Park
Milton Road
Cambridge CB4 0WG, GB,
KENDREW, Jane, AstraZeneca
Alderley Park
Macclesfield
Cheshire SK10 4TG, GB,
HO, Tony, AstraZeneca Pharmaceuticals LP
One Medlmmune Way
Gaithersburg, MD 20878, US,
WEDGE, Stephen, Robert, AstraZeneca
Riverside Buildnig 2
Granta Park
Cambridge CB21 6GH, GB,
KOHN, Elise, National Institutes of Health
6011 Executive Boulevard
Suite 325
MSC 7660
Bethesda, MD 20892-7660, US,
LEE, Jung-Min, National Institutes of Health
6011 Executive Boulevard
Suite 325
MSC 7660
Bethesda, MD 20892-7660, US,
IVY,Susan Percy, National Institutes of Health
6011 Executive Boulevard
Suite 325
MSC 7660
Bethesda, MD 20892-7660, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 31/502 (2006.01) , A61K 31/506 (2006.01) , A61K 38/00 (2006.01) , A61K 39/395 (2006.01) , A61K 45/06 (2006.01) , A61K 48/00 (2006.01) , A61P 35/00 (2006.01) , A61P 43/00 (2006.01) , A61P 9/10 (2006.01) , C07K 16/28 (2006.01) , G01N 33/574 (2006.01) | | Title | FREMGANGSMÅDER, SOM OMFATTER FAST INTERMITTERENDE DOSERING AF CEDIRANIB | | Int. application no. | US2017017804 | | Int. publication no. | WO2017142871 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
